VOYA INVESTMENT MANAGEMENT LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$63,000
-24.1%
21,295
+15.1%
0.00%
Q4 2021$83,000
-9.8%
18,500
-2.0%
0.00%
Q3 2021$92,000
-28.7%
18,8760.0%0.00%
Q2 2021$129,000
-10.4%
18,876
-7.2%
0.00%
Q1 2021$144,000
+13.4%
20,3440.0%0.00%
Q4 2020$127,000
+62.8%
20,344
+40.5%
0.00%
Q3 2020$78,000
+2.6%
14,4830.0%0.00%
Q2 2020$76,000
+40.7%
14,483
-15.7%
0.00%
Q1 2020$54,000
-29.9%
17,189
-10.2%
0.00%
Q4 2019$77,000
+35.1%
19,141
+45.5%
0.00%
Q3 2019$57,000
+9.6%
13,1520.0%0.00%
Q2 2019$52,000
-25.7%
13,1520.0%0.00%
Q1 2019$70,000
+4.5%
13,1520.0%0.00%
Q4 2018$67,000
-47.7%
13,1520.0%0.00%
Q3 2018$128,000
-4.5%
13,1520.0%0.00%
Q2 2018$134,000
-2.2%
13,152
+24.4%
0.00%
Q1 2018$137,000
-27.5%
10,5730.0%0.00%
Q4 2017$189,000
-28.7%
10,5730.0%0.00%
-100.0%
Q3 2017$265,000
+3.9%
10,5730.0%0.00%0.0%
Q2 2017$255,00010,5730.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,138,872$55,119,00027.83%
Abingworth LLP 1,301,413$33,524,00015.22%
Roumell Asset Management, LLC 207,703$5,353,0009.43%
GREAT POINT PARTNERS LLC 415,338$10,703,0004.17%
Aisling Capital LLC 682,680$17,593,0002.62%
Broadfin Capital, LLC 530,283$13,665,0000.73%
Baupost Group 1,544,498$39,802,0000.66%
Tekla Capital Management LLC 691,000$17,807,0000.64%
GENERAL AMERICAN INVESTORS CO INC 277,076$7,140,0000.59%
Lombard Odier Asset Management (USA) Corp 140,000$3,607,0000.26%
View complete list of PARATEK PHARMACEUTICALS INC shareholders